ARCHIVES

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

This article is from The Cancer Letter archive.

Vol. 14 No. 38 | September 30, 1988

Download PDF Visit The Full Archive

Related Articles

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

NCI Offers Mouse Strains, Tissue Microarrays, Online.

March 9, 2001

In Brief: Ovarian Cancer Coalition Opens Office; Winchester Leads Surgical Oncologists

July 11, 1997

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

UICC Announces Four Grant award Programs

July 14, 1978